Study of Personalized Tumor Vaccines (PCVs) and a PD-L1 Blocker in Patients With Pancreatic Cancer That Can be Treated With Surgery
Clinical trial NCT04161755 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04161755
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-13
- Primary completion
- 2026-11-11
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.